Concepedia

Ryan Iarrobino

RI

Statistics

Publications

7

Citations

423

H-Index

7

Active since

2012

Affiliations

Takeda (United States)(Current)

Scholar Rock (United States)

Institute for Asthma and Allergy

Washington University in St. Louis

University of Cincinnati

Ryan Iarrobino is an author at Takeda (United States) specializing in clinical pharmacology, pharmacology, and pharmacotherapy.

ORCID

Publications per year

2012–2024

7

Publications

7

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis

Aleena Banerji, Paula J. Busse, Mustafa M. Shennak et al. · New England Journal of Medicine · 2017 · 171 citations · Full text

, , +13

Ecallantide for the Acute Treatment of Angiotensin-Converting Enzyme Inhibitor–Induced Angioedema: A Multicenter, Randomized, Controlled Trial

Lawrence M. Lewis, Charles S. Graffeo, Pascal Crosley et al. · Annals of Emergency Medicine · 2014 · 67 citations · Full text

, , +3

A phase 1 study investigating DX-2930 in healthy subjects

Yung Chyung, Bradley Vince, Ryan Iarrobino et al. · Annals of Allergy Asthma & Immunology · 2014 · 60 citations · Full text

, , +13

Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3

Thomas O. Crawford, Basil T. Darras, John Day et al. · Neurology · 2024 · 43 citations · Full text

, , +17

A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy

D Barrett, Sanela Bilic, Yung Chyung et al. · Advances in Therapy · 2021 · 42 citations · Full text

, , +14

1–5 of 7